Papp, Z, Agostoni, P, Alvarez, J, Bettex, D, Bouchez, S, Brito, D, Cerny, V, Comin-Colet, J, Crespo-Leiro, MG, Delgado, JF, Edes, I, Eremenko, AA, Farmakis, D, Fedele, F, Fonseca, C, Fruhwald, S, Girardis, M, Guarracino, F
, Harjola, V-P, Heringlake, M, Herpain, A, Heunks, LMA, Husebye, T, Ivancan, V, Karason, K, Kaul, S, Kivikko, M, Kubica, J, Masip, J, Matskeplishvili, S, Mebazaa, A
, Nieminen, MS, Oliva, F, Papp, JG, Parissis, J, Parkhomenko, A, Poder, P, Poelzl, G, Reinecke, A, Ricksten, S-E, Riha, H, Rudiger, A, Sarapohja, T, Schwinger, RHG, Toller, W, Tritapepe, L, Tschoepe, C, Wikstroem, G, von Lewinski, D, Vrtovec, B & Pollesello, P 2020, '
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use',
Journal of Cardiovascular Pharmacology, Vuosikerta 76, Nro 1, Sivut 4-22.
https://doi.org/10.1097/FJC.0000000000000859